Clinical Trials Directory

Trials / Completed

CompletedNCT05618509

Immediate Effects of STENDO on the Walking Abilities of Patients with COPD (STENDO-COPD)

Immediate Effects of STENDO on the Walking Abilities of Patients with COPD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Elsan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The STENDO process is a heart rate synchronized massage system initially validated for the treatment of lymphedema. It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. This technique would also allow an improvement of endothelial function by a greater release of nitric oxide. Thus the capacity for physical exercise is potentially improved. The use of STENDO has never been evaluated in COPD (Chronic obstructive pulmonary disease) where physical capacity is impaired with, in particular, the presence of endothelial dysfunction. STENDO may improve walking performance. If these hypotheses are validated, the STENDO could be positioned as a complement to the exercise rehabilitation strategies offered to symptomatic COPD patients.

Conditions

Interventions

TypeNameDescription
DEVICESTENDO sessionIt is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. The capacity for physical exercise is potentially improved. STENDO : 45 minutes, 2 legs and the pelvis, pression of 65mm Hg
OTHERA six-minute walking distance testBefore and after STENDO session, the patient has to walk 6 minutes in a flat corridor (30m long)
OTHERNear Infrared SpectroscopyThe goal is to measure the evolution of the oxygen consumption of the right leg during an effort on a bicycle at constant power for 5 minutes.
DEVICESTENDO placeboSTENDO placebo : 45 minutes, on 2 legs and the pelvis, pression of 10 mmHg

Timeline

Start date
2023-01-04
Primary completion
2024-05-27
Completion
2024-05-27
First posted
2022-11-16
Last updated
2024-09-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05618509. Inclusion in this directory is not an endorsement.